Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study)

M Trojano; J Hobart; G Kobelt; VV Pesch; A Rovira; R Kantaria; L Craveiro; D Dzhenkova; W Wei; R Alroughani

doi:10.1016/j.msard.2018.10.083

Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study)

M Trojano, J Hobart, G Kobelt, VV Pesch, A Rovira, R Kantaria, L Craveiro, D Dzhenkova, W Wei, R Alroughani

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1016/j.msard.2018.10.083
Publication status	Published - Nov 2018

Access to Document

10.1016/j.msard.2018.10.083

Cite this

Trojano, M., Hobart, J., Kobelt, G., Pesch, VV., Rovira, A., Kantaria, R., Craveiro, L., Dzhenkova, D., Wei, W., & Alroughani, R. (2018). Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study). https://doi.org/10.1016/j.msard.2018.10.083

@conference{7c3ec1b0feb64fde8b1649a37eccd4e4,

title = "Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study)",

author = "M Trojano and J Hobart and G Kobelt and VV Pesch and A Rovira and R Kantaria and L Craveiro and D Dzhenkova and W Wei and R Alroughani",

year = "2018",

month = nov,

doi = "10.1016/j.msard.2018.10.083",

language = "English",

}

Trojano, M, Hobart, J, Kobelt, G, Pesch, VV, Rovira, A, Kantaria, R, Craveiro, L, Dzhenkova, D, Wei, W & Alroughani, R 2018, 'Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study)'. https://doi.org/10.1016/j.msard.2018.10.083

TY - CONF

T1 - Novel Assessment of Real-world Effectiveness of Ocrelizumab for Treatment of Patients with Relapsing and Primary Progressive Multiple Sclerosis: Design of a Multicenter Non-interventional Study (musicale Study)

AU - Trojano, M

AU - Hobart, J

AU - Kobelt, G

AU - Pesch, VV

AU - Rovira, A

AU - Kantaria, R

AU - Craveiro, L

AU - Dzhenkova, D

AU - Wei, W

AU - Alroughani, R

PY - 2018/11

Y1 - 2018/11

U2 - 10.1016/j.msard.2018.10.083

DO - 10.1016/j.msard.2018.10.083

M3 - Conference paper (not formally published)

ER -